In the quest for effective treatments against COVID-19, two familiar medications, metformin, and atorvastatin, have emerged as promising candidates. Recent studies have shed light on their potential to modulate the immune system and combat the virus, offering hope in the fight against the global pandemic.
Amidst the challenges posed by COVID-19, the World Trade Organization’s Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) has been actively involved in addressing the need for therapeutics and diagnostics. While consensus on extending the Ministerial Decision on the TRIPS Agreement to cover COVID-19 was not reached, the Council remains dedicated to finding solutions for future pandemics through voluntary licensing and technology transfer.
The review emphasizes the advantages of repurposing existing medications for COVID-19 treatment, citing the safety profiles and widespread availability of metformin and atorvastatin as key factors. As the world continues to combat the virus, the discovery of these potential treatments offers a glimmer of hope for a brighter future.
As research progresses and global organizations work towards pandemic preparedness, the exploration of metformin and atorvastatin as COVID-19 treatments holds significant promise. With ongoing collaboration and innovation, these medications may soon play a vital role in the world’s defense against not only the current crisis but also future health challenges.
